A transcatheter pulmonary valve for use in patients with dysfunctional right ventricular outflow tract (RVOT) conduits has shown a high rate of procedural success and encouraging short-term function, despite some concern about reinterventions for stent fractures. The findings, which represent updated results from those presented to the US Food and Drug Administration, were published online July 19, 2010, ahead of print in Circulation.
